Clik here to view.
Ysios Capital raises $140m for 2nd life science fund
Biotech venture capital firm Ysios Capital said today it has raised $140 million (€126.4 million) for its 2nd life science fund, Ysios BioFund II Innvierte. The closing exceeded its initial target of...
View ArticleClik here to view.
Abbott holds steady on St. Jude Medical, Alere buyouts
(Reuters) — Abbott (NYSE:ABT) said today that it’s pushing ahead to complete its planned purchases of medical device maker St. Jude Medical (NYSE:STJ) and diagnostics company Alere (NYSE:ALR) despite...
View ArticleClik here to view.
Cerulean, Novartis ink $5m deal to co-develop nanoparticle-drug conjugates
Cerulean Pharma Inc. (NSDQ:CERU) said today that it inked a deal with Novartis (NYSE:NVS) to develop nanoparticle-drug conjugates. The products will match Cerulean’s tumor-targeting tech with Novartis...
View ArticleClik here to view.
CareFusion lays off 128 in California
Becton Dickinson (NYSE:BDX) subsidiary CareFusion is laying off workers in California, according to a Worker Adjustment & Retraining Notification Act notice. CareFusion, which this month landed a...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for October 19, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Medtronic warns on deep brain stimulation charger issue
Medtronic (NYSE:MDT) warned customers this month of an issue with some of its Model 37751 rechargers for its deep-brain stimulation devices, saying they may become unresponsive and unable to fully...
View ArticleClik here to view.
US FDA adopts IMDRF software as medical device clinical evaluation proposals
By Stewart Eisenhart, Emergo Group EMERGO SUMMARY OF KEY POINTS: US regulators are fashioning new guidance on software as a medical device (SaMD) based on IMDRF principles. The degree of clinical...
View ArticleClik here to view.
iRhythm prices IPO above the range, raises $107m
iRhythm Technologies yesterday increased the scale of its initial public offering, pricing the flotation above its prior range at $17 per share and increasing the number of shares on offer. Earlier...
View ArticleClik here to view.
Bigfoot Biomedical raises $36m Series A for Smartloop artificial pancreas...
Bigfoot Biomedical said yesterday that it raised $35.5 million in a Series A round for the artificial pancreas technology it’s developing to treat Type I diabetes. The round, led by Quadrant Capital...
View ArticleClik here to view.
Whistleblower drops some claims in Medtronic insulin pump suit
The whistleblower in a lawsuit accusing Medtronic (NYSE:MDT) of marketing its insulin pumps for off-label uses and running a kickbacks scheme to drive new sales withdrew some state claims from the...
View ArticleClik here to view.
Cartiva’s water-based implant for big toe damage
(Reuters) — When the painkillers stop working, arthritic joint damage in the big toe can make even the weight of a bedsheet agonizing. Standard surgery eliminates that pain by removing the cartilage...
View ArticleClik here to view.
Stryker recalls Boston Scientific Guider guide cath
Stryker‘s (NYSE:SYK) neurovascular division this month released a recall notice for Boston Scientific‘s (NYSE:BSX) Guider guide catheter it distributes over issues with an incomplete seal that could...
View ArticleClik here to view.
Akesys, Elixir Medical tout 1st implant for Prava bioresorbable peripheral stent
Akesys Medical and Elixir Medical Corporation said today that it implanted its 1st Prava sirolimus eluting bioresorbable peripheral scaffold for the treatment of blockages in the superficial femoral...
View ArticleClik here to view.
Mylan, Theravance touts Phase III data for COPD drug
Mylan (NSDQ:MYL) and Theravance Biopharma, Inc. (NSDQ:TBPH) said today that revefenacin, the 1st nebulized bronchodilator in development for the treatment of chronic obstructive pulmonary...
View ArticleClik here to view.
EnteroMedics shareholders reject reverse split, annual meeting canceled
EnteroMedics (NSDQ:ETRM) said yesterday it cancelled a special meeting of stockholders it had scheduled to vote on increasing stock numbers and initiating a reverse stock split after a lack of support...
View ArticleClik here to view.
Getinge to spin out Patient & Post-Acute Care business, earnings
Getinge (PINK:GETI B) said Tuesday it is looking to spin-out its Patient & Post-Acute Care businesses in an attempt to strategically ensure sustainable growth at the company. The move comes as the...
View ArticleClik here to view.
Emulate, LabCorp’s Covance launch organ-on-a-chip program
Emulate, Inc. and LabCorp‘s (NYSE:LH) Covance Drug Development biz inked a deal to collaborate for an organ-on-a-chip preclinical drug evaluation and testing service. Emulate’s organ-on-a-chip tech is...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for October 20, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
J&J and Google’s Verb Surgical looks to define, lift robotic surgery
Robotic surgery units available on the market right now are not ‘robots,’ according to Johnson & Johnson (NYSE:JNJ) worldwide medical devices chair Gary Pruden. But Verb Surgical, J&J’s joint...
View ArticleClik here to view.
Propeller Health raises $22m in Series C
Propeller Health said today it closed a $21.5 million Series C round of financing, with funds salted to help expand the company’s digitally-guided therapy platform. The fund was joined by newly...
View Article